Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Exagen Inc (XGN)
NASDAQ:XGN
Exagen (XGN) Stock Price & Analysis
98 Followers
XGN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.33 - $3.92
Previous Close$1.56
Volume26.05K
Average Volume (3M)43.27K
Market Cap
$26.89M
Enterprise Value$22.66M
Total Cash (Recent Filing)$28.45M
Total Debt (Recent Filing)$24.22M
Price to Earnings (P/E)-1.2
Beta0.81
Next Earnings
May 13, 2024EPS Estimate
-$0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.34
Shares Outstanding17,235,751
10 Day Avg. Volume90,046
30 Day Avg. Volume43,272
Standard Deviation0.17
R-Squared0.15
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.17
Price to Sales (P/S)0.59
Price to Cash Flow (P/CF)0.80
P/FCF Ratio0.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.45
Enterprise Value/Gross Profit1.06
Enterprise Value/Ebitda-0.75
Forecast
1Y Price Target
$5.67Price Target Upside256.60% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Ownership Overview
56.44% Insiders
8.39% Mutual Funds
27.82% Other Institutional Investors
7.35% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
XGN FAQ
What was Exagen Inc’s price range in the past 12 months?
Exagen Inc lowest stock price was $1.33 and its highest was $3.92 in the past 12 months.
What is Exagen Inc’s market cap?
Currently, no data Available
When is Exagen Inc’s upcoming earnings report date?
Exagen Inc’s upcoming earnings report date is May 13, 2024 which is in 23 days.
How were Exagen Inc’s earnings last quarter?
Exagen Inc released its earnings results on Mar 18, 2024. The company reported -$0.31 earnings per share for the quarter, beating the consensus estimate of -$0.43 by $0.12.
Is Exagen Inc overvalued?
According to Wall Street analysts Exagen Inc’s price is currently Undervalued.
Does Exagen Inc pay dividends?
Exagen Inc does not currently pay dividends.
What is Exagen Inc’s EPS estimate?
Exagen Inc’s EPS estimate is -$0.36.
How many shares outstanding does Exagen Inc have?
Exagen Inc has 17,235,750 shares outstanding.
What happened to Exagen Inc’s price movement after its last earnings report?
Exagen Inc reported an EPS of -$0.31 in its last earnings report, beating expectations of -$0.43. Following the earnings report the stock price went up 9.259%.
Which hedge fund is a major shareholder of Exagen Inc?
Among the largest hedge funds holding Exagen Inc’s share is Platinum Investment Management. It holds Exagen Inc’s shares valued at N/A.
---
Exagen Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5.67 (256.60% Upside)
$5.67 (256.60% Upside)
Hedge Fund Trend
Decreased
By 264.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $37.4K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.94%
12-Months-Change
Fundamentals
Return on Equity
-72.72%
Trailing 12-Months
Asset Growth
-35.02%
Trailing 12-Months
Company Description
Exagen Inc
Exagen Diagnostics Inc was incorporated under the laws of the state of New Mexico in 2002. The Company is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets four products under its Avise brand to provide an accurate, timely and differential diagnosis and to optimize the treatment of ARDs. It processed approximately 9,300 patient specimens for its diagnostic product line, Avise SLE. It markets and sells solutions to community rheumatologists.
---
XGN Earnings Call
Q4 2024
0:00 / 0:00
---
XGN Stock 12 Months Forecast
Average Price Target
$5.67
▲(256.60% Upside)
Technical Analysis
Best Analysts Covering XGN
1 Year
1 Year Success Rate
1/8 ratings generated profit
1 Year Average Return
-31.42%
reiterated a buy rating last month
Copying Kyle Mikson CFA's trades and holding each position for 1 Year would result in 12.50% of your transactions generating a profit, with an average return of -31.42% per trade.
---